Lidocaine Hydrochloride/Menthol

盐酸利多卡因/薄荷脑

Report date: 2023/02/17 20:00:35

Base Information

Drug NameLidocaine Hydrochloride/Menthol
Drug Alias Name复方盐酸利多卡因注射液
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockersTransient receptor potential cation channel subfamily M member 8 agonists
TargetsSodium channel alpha subunitTransient receptor potential cation channel subfamily M member 8
Therapy Area/IndicationsPain, PostoperativeAnesthesia
Global Approved IndicationsPain, Postoperative
Approved Indications in ChinaPain, Postoperative
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Lidocaine HydrochlorideMenthol
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Jinyao Amino Acid Co Ltd
Inactive CompaniesN/A
Active IndicationsPain, PostoperativeAnesthesia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A